OREXIGEN THERAPEUTICS INC - COM (OREX)

CUSIP: 686164104

Q2 2013 13F Holders as of 30 Jun 2013

Type / Class
Equity / COM
Total 13F shares
5,284,355
Share change
+1,366,525
Total reported value
$30,891,000
Price per share
$5.85
Number of holders
6
Value change
+$7,987,334
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP 686164104?
CUSIP 686164104 identifies OREX - OREXIGEN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q2 2013

As of 30 Jun 2013, OREXIGEN THERAPEUTICS INC - COM (OREX) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,284,355 shares. The largest 6 holders included Partner Fund Management, L.P., CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, Partner Investment Management, L.P., Forward Management, LLC, and Joel Isaacson & Co., LLC. This page lists 6 institutional shareholders reporting positions in this security for the Q2 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.